$252.04
0.37% yesterday
NYSE, Nov 07, 10:01 pm CET
ISIN
US4448591028
Symbol
HUM

Humana Stock News

Neutral
Business Wire
one day ago
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Celeste Mellet, Chief Financial Officer, will make a presentation to investors at the Wolfe Research Healthcare Conference on Wednesday, November 19, 2025, at 8:40 a.m. Eastern time. A live audio webcast of the presentation will be available via Humana's Investor Relations page at https://humana.gcs-web.com/. The com...
Neutral
Seeking Alpha
2 days ago
Humana Inc. ( HUM ) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Company Participants Lisa Stoner - Vice President of Investor Relations James Rechtin - President, CEO & Director Celeste Mellet - Chief Financial Officer David Dintenfass - President of Enterprise Growth George Renaudin - President of Insurance Conference Call Participants Andrew Mok - Barclays Bank PLC, Research Division A...
Neutral
Seeking Alpha
2 days ago
Humana receives a "Hold" rating due to fair valuation and ongoing underperformance versus the S&P 500. HUM's Q3 earnings beat expectations, but a light FY 2025 outlook and higher medical loss ratio pressured shares. Management aims to double Medicare Advantage margins by 2026, but faces headwinds from declining membership and regulatory changes.
Negative
Market Watch
2 days ago
Medicaid-membership growth outlook was slashed, and as medical costs are still a problem.
Positive
Forbes
3 days ago
Humana Wednesday reported $195 million in third quarter profits as the health insurer's medical cost trends were in line with the company's earlier forecasts.
Negative
WSJ
3 days ago
Humana reported lower third-quarter profit and slashed full-year earnings guidance as medical costs continue to surge, dragging down margins for the company's core Medicare Advantage business.
Positive
Reuters
3 days ago
Humana reported third-quarter profit that beat Wall Street estimates on Wednesday, on higher premiums.
Neutral
Business Wire
3 days ago
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended September 30, 2025 (3Q25) versus the quarter ended September 30, 2024 (3Q24) and for the nine months ended September 30, 2025 (YTD 2025) versus the nine months ended September 30, 2024 (YTD 2024) as noted in the tables below. Consolidate...

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today